The Fight - Last month, ViiV revealed results from two studies, pairing its own cabotegravir with Johnson & Johnson’s rilpivirine (branded as Edurant). When given once every four weeks, the drugs can maintain viral suppression in HIV-positive adults as well as a standard three-drug regimen taken daily. The data will be part of the approval application ViiV submits to regulatory authorities later this year, reports

LA Blade - The Los Angeles County Board of Supervisors unanimously passed a motion on Nov. 20 to approve the allocation of emergency reserve funds for organizations, including the Los Angeles LGBT Center, for public health initiatives like STD testing and treatment.

The motion, introduced by Supervisors Sheila Kuehl and Mark Ridley-Thomas, will add $5 million for public health programs, along with $1 million in grant funding for clients with substance abuse disorders, over a period of two years.

LA Blade - Pharmaceutical giant Gilead was hit with a lawsuit filed by 41 people from 12 states on April 11 who allege they suffered bone and/or kidney damage after taking Gilead’s tenofovir disoproxil fumarate, (TDF). The personal injury suit, filed in California Superior Court in Los Angeles, alleges the pharmaceutical company knew in 2001 that TDF was “highly toxic in the doses prescribed and risked permanent and possibly fatal damage to the kidneys and bones” —and that there was a safer alternative.

“More and more plaintiffs are coming forward to tell their stories of how they have been harmed by Gilead’s practice of putting profits over patient health,” said Liza Brereton with HIV Litigation Attorneys.

GayLifeLA - A California resident is the sixth person in the world identified thus far as having become infected with HIV despite being on a daily PrEP regimen.

That infection was reported at the annual IDWeek conference in San Francisco last week. PrEP, or pre-exposure prophylaxis, is a regimen that requires taking a daily dose of the drug Truvada. It has been proven to reduce the chance of becoming infected with HIV by 99%.

Page 1 of 3

Mailing List